Guide coverage

Exosome sourcing guides by state

10 of 50 state guides are published. This table is generated from the guide registry, so a state gains a link the moment its guide is reviewed and never before. States without a link are in research or review.

Most recent guide review:

All 50 states

Every state in the registry, whether its exosome sourcing guide is published, and the guide link where one exists
StateCodeGuideReviewed
AlabamaALIn review
AlaskaAKIn review
ArizonaAZPublished2026-08-09
ArkansasARIn review
CaliforniaCAPublished2026-08-09
ColoradoCOPublished2026-08-09
ConnecticutCTIn review
DelawareDEIn review
FloridaFLPublished2026-08-09
GeorgiaGAPublished2026-08-09
HawaiiHIIn review
IdahoIDIn review
IllinoisILIn review
IndianaINIn review
IowaIAIn review
KansasKSIn review
KentuckyKYIn review
LouisianaLAIn review
MaineMEIn review
MarylandMDIn review
MassachusettsMAIn review
MichiganMIIn review
MinnesotaMNIn review
MississippiMSIn review
MissouriMOIn review
MontanaMTIn review
NebraskaNEIn review
NevadaNVPublished2026-08-09
New HampshireNHIn review
New JerseyNJPublished2026-08-09
New MexicoNMIn review
New YorkNYPublished2026-08-09
North CarolinaNCIn review
North DakotaNDIn review
OhioOHIn review
OklahomaOKIn review
OregonORIn review
PennsylvaniaPAIn review
Rhode IslandRIIn review
South CarolinaSCIn review
South DakotaSDIn review
TennesseeTNPublished2026-08-09
TexasTXPublished2026-08-09
UtahUTIn review
VermontVTIn review
VirginiaVAIn review
WashingtonWAIn review
West VirginiaWVIn review
WisconsinWIIn review
WyomingWYIn review

About the guides

How many state sourcing guides has ExaVeyra published?
10 of 50 state guides are published. The remaining 40 are listed on the coverage page without a link and appear as each is researched and reviewed.
Which states have a published exosome sourcing guide?
Guides are published for Arizona, California, Colorado, Florida, Georgia, Nevada, New Jersey, New York, Tennessee and Texas. Each one is linked from the coverage table.
What does a state sourcing guide cover?
Each guide reads the state's regenerative-medicine statute for what it does and does not reach, who in a practice may handle product under the state's delegation rules, which boards are involved, and cold-chain transit for the state's metros, with every regulatory statement cited to a primary source. The most recent review date across the published guides is 2026-08-09.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic treatments in clinics and for medical, molecular biology, and biochemistry research applications.

This page lists which guides are published. It is not a statement about licensure, distribution or availability in any state, and it is not legal advice; each guide cites its sources and carries its own review date.